News for '-v-2'

DCGI approves commercial launch of low-cost Covid test 'Feluda'

DCGI approves commercial launch of low-cost Covid test 'Feluda'

Rediff.com20 Sep 2020

This test uses an indigenously developed, cutting-edge CRISPR technology for detection of the genomic sequence of SARS-CoV-2 virus, CSIR said in a statement.

Bharat Biotech's Covaxin shipped to 11 cities in India

Bharat Biotech's Covaxin shipped to 11 cities in India

Rediff.com13 Jan 2021

After having received the government purchase order for 55 lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram (Vijayawada), Guwahati, Patna, Delhi, Kurukshetra, Bangalore, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow.

'COVID-19 is deadly in 0.1 per cent people'

'COVID-19 is deadly in 0.1 per cent people'

Rediff.com20 Oct 2020

'Some of the longer-term implications of COVID-19 are not related to the virus itself.' 'They are actually related to immune responses from the virus.'

India detects 2 more Omicron Covid cases; total tally reaches 4

India detects 2 more Omicron Covid cases; total tally reaches 4

Rediff.com4 Dec 2021

Cases with the Omicron variant have already been detected in Karnataka and Gujarat.

Flyers subject to random sampling can leave after giving samples: Govt

Flyers subject to random sampling can leave after giving samples: Govt

Rediff.com1 Dec 2021

The ministry of civil aviation on Wednesday said only two per cent of the passengers coming from countries that are not in the 'at-risk' list will be subject to random sampling for coronavirus and such passengers will be permitted to leave the airport after giving the samples.

82 cases of new strain of COVID-19 in India: Govt

82 cases of new strain of COVID-19 in India: Govt

Rediff.com8 Jan 2021

All the people who have tested positive for the new variant of the virus were kept in single-room isolation at designated healthcare facilities by the respective state governments, the ministry had earlier said.

COVID-19: 'We will be dealing with it for 2 years at least'

COVID-19: 'We will be dealing with it for 2 years at least'

Rediff.com29 Oct 2020

'The most intriguing thing (about COVID-19) is the range of the illness -- from asymptomatic or less symptoms to death and quite severe manifestations.' 'The vaccine will be at least another year away from having any effect.'

How bats carry coronavirus without getting sick

How bats carry coronavirus without getting sick

Rediff.com7 May 2020

Instead of killing bat cells as the virus does with human cells, the MERS coronavirus enters a long-term relationship with the host, maintained by the bat's unique 'super' immune system

No case of new variant detected at Delhi airport: Lab

No case of new variant detected at Delhi airport: Lab

Rediff.com27 Nov 2021

The Centre had on Thursday asked all states and union territories to conduct rigorous screening and testing of all international travellers coming from or transiting through South Africa, Hong Kong and Botswana, where the B.1.1.529 variant has been detected.

Oxford vaccine doing 'everything expected': Study

Oxford vaccine doing 'everything expected': Study

Rediff.com22 Oct 2020

A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.

Mixing COVID-19 vaccines gives good protection: Study

Mixing COVID-19 vaccines gives good protection: Study

Rediff.com29 Jun 2021

According to the study, 'mixed' schedules of these vaccines induced high concentrations of antibodies against the SARS-CoV2 spike IgG protein when doses were administered four weeks apart.

Scientists identify new antibody that limits severity of coronavirus

Scientists identify new antibody that limits severity of coronavirus

Rediff.com3 Nov 2021

Scientists have identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the SARS illness.

'The severe cases are mostly unvaccinated people'

'The severe cases are mostly unvaccinated people'

Rediff.com28 Dec 2021

'In our ICUs, the majority are unvaccinated people.' 'Out of the hospital, in the community, we see that -- whether you are vaccinated or whether you're not vaccinated -- the symptoms are more or less the same.'

Gallbladder gangrene reported in post-Covid patients

Gallbladder gangrene reported in post-Covid patients

Rediff.com16 Sep 2021

Doctors claimed it is the first time that cases of gallbladder gangrene have been reported after recovery from COVID-19 infection.

'Delta Plus' now variant of concern; 22 cases found: Govt

'Delta Plus' now variant of concern; 22 cases found: Govt

Rediff.com22 Jun 2021

22 cases of the Delta Plus variant of the coronavirus have been detected in India, with 16 of them being reported from Maharashtra and the remaining from Madhya Pradesh and Kerala, the government said.

Malicious COVID vaccine SMS spreading: Cyber agency

Malicious COVID vaccine SMS spreading: Cyber agency

Rediff.com10 May 2021

It asked users to be alert against all attempts of phishing through fake domains, emails and text messages that promise registration for a jab against the pandemic.

COVID: UK variant dominates North India, double mutant in Maha, Guj, K'taka

COVID: UK variant dominates North India, double mutant in Maha, Guj, K'taka

Rediff.com6 May 2021

The double mutant variant, also known as B.1.617, is mostly dominating Maharashtra (761), West Bengal (124), Delhi (107) and Gujarat (102).

Three PSG players test positive for COVID-19

Three PSG players test positive for COVID-19

Rediff.com2 Sep 2020

Three Paris St Germain players have tested positive for COVID-19, the Ligue 1 club said on Wednesday without revealing their identities.

New rules: No Covid test for kids arriving from abroad

New rules: No Covid test for kids arriving from abroad

Rediff.com11 Nov 2021

Children below five years are exempted from both pre- and post-arrival testing for COVID-19 in India, according to the revised guidelines for international arrivals released on Thursday.

Spread of Delta variant will substantially up cases: WHO

Spread of Delta variant will substantially up cases: WHO

Rediff.com14 Jul 2021

As of July 13, at least 111 countries, territories and areas have reported detection of the Delta variant, and this is expected to continue to increase, becoming the dominant variant globally in the coming months.

India detects new 'double mutant' variant of COVID-19

India detects new 'double mutant' variant of COVID-19

Rediff.com24 Mar 2021

The ministry, however, said it could not be sufficiently established yet if these variants were behind the recent spike in COVID-19 cases in some states.

TN makes negative rt-pcr/vax certificate must for Kerala travellers

TN makes negative rt-pcr/vax certificate must for Kerala travellers

Rediff.com1 Aug 2021

The Tamil Nadu government on Sunday said it was mandatory for people coming from Kerala, to the state to carry a negative RT-PCR test report or vaccination certificate of two COVID doses from August 5, in the wake of a spike in infections in the neighbouring state.

'Indian strain' of coronavirus found in 17 countries: WHO

'Indian strain' of coronavirus found in 17 countries: WHO

Rediff.com28 Apr 2021

The WHO said that studies have highlighted that the spread of the second wave has been much faster than the first in India.

Scientists say Oxford Covid vaccine looks safe, induces immunity

Scientists say Oxford Covid vaccine looks safe, induces immunity

Rediff.com20 Jul 2020

The results show they induced strong antibody and T-cell immune responses for up to 56 days after they were given. T-cells are crucial for maintaining protection against the virus for years.

British intel report says Covid may have leaked from Chinese lab

British intel report says Covid may have leaked from Chinese lab

Rediff.com31 May 2021

British intelligence agencies now believe it is 'feasible' that the COVID-19 pandemic began with a coronavirus leak from a Chinese bio laboratory, a media report said here on Sunday, prompting Vaccines Minister Nadhim Zahawi to demand that the World Health Organisation (WHO) must fully investigate the origins of the deadly virus.

Covid infection is not severe in kids, send them to school: Dr Gagandeep Kang

Covid infection is not severe in kids, send them to school: Dr Gagandeep Kang

Rediff.com31 Dec 2021

"In children, fortunately, infections with SARS-CoV-2 are generally not severe. There is a risk of long COVID, there is a risk of a very, very rare condition called MISC (Multisystem Inflammatory Syndrome) but by and large healthy children have nothing," said Dr Gagandeep Kang, leading Indian virologist.

Six feet gap not enough to prevent virus spread, says study

Six feet gap not enough to prevent virus spread, says study

Rediff.com15 Sep 2021

Physical distancing of two metres - about six and a half feet - may not be enough to sufficiently prevent transmission of virus-carrying airborne aerosols indoors, says a study.

Shortage of key chemical from US hits Covaxin ramp-up plans

Shortage of key chemical from US hits Covaxin ramp-up plans

Rediff.com22 Apr 2021

'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'

UK hospital told to prep for COVID vaccine by Nov: Report

UK hospital told to prep for COVID vaccine by Nov: Report

Rediff.com26 Oct 2020

The vaccine, ChAdOx1 nCoV-19 and also known as AZD1222, is considered among the most advanced in the worldwide hunt for a viable vaccine against the novel coronavirus.

Mask mandate can be removed for now, say experts

Mask mandate can be removed for now, say experts

Rediff.com8 Apr 2022

The assurance comes as India's Covid graph dips -- on Friday 1,109 new coronavirus infections were reported -- and also one case of a new Covid strain in Mumbai.

Delhi's Covid surge no sign of 4th wave, say health experts

Delhi's Covid surge no sign of 4th wave, say health experts

Rediff.com19 Apr 2022

Though Covid cases are rising in Delhi and its satellite towns, the focus should be on hospital admissions that have remained the same or changed just marginally, say several scientists, underscoring that the uptick is not an indication of a fourth wave in the country at this point.

India has developed first DNA vaccine for COVID-19: Modi @ UNGA

India has developed first DNA vaccine for COVID-19: Modi @ UNGA

Rediff.com25 Sep 2021

Prime Minister Narendra Modi, in his address at the 76th session of the United Nations General Assembly on Saturday, invited the global manufacturers of vaccines to come and make vaccines in India, stressing that the country's "faith is to serve people".

66% adults given at least one COVID-19 vaccine jab: Govt

66% adults given at least one COVID-19 vaccine jab: Govt

Rediff.com23 Sep 2021

Addressing a press conference, Union health secretary Rajesh Bhushan said 63.7 per cent vaccine doses have been administered in rural areas and 35.4 per cent in urban areas.

'All the vaccines, so far, seem to be protecting from severe illness'

'All the vaccines, so far, seem to be protecting from severe illness'

Rediff.com9 Nov 2021

'The immune protection may well wane somewhat, and that's what we have to monitor.' 'Should it wane to the point where vaccinated individuals are getting severe disease, then we really will need to give them booster shots and that'll apply regardless of what vaccine they've got the first time.'

Omicron overtakes Delta; less severe but not mild: WHO

Omicron overtakes Delta; less severe but not mild: WHO

Rediff.com12 Jan 2022

"Omicron has been detected in all countries where we have good sequencing and it's likely to be in all countries around the world. It is quickly, in terms of its circulation, overtaking Delta. And so Omicron is becoming the dominant variant that is being detected," Kerkhove said during a virtual questions and answers session.

Trials find Covid vax safe for kids aged 5-11 yrs: Pfizer, BioNTech

Trials find Covid vax safe for kids aged 5-11 yrs: Pfizer, BioNTech

Rediff.com20 Sep 2021

Pfizer and BioNTech SE on Monday said trial results of COVID-19 vaccine showed that it is safe and produced robust neutralising antibody response in children aged five to 11 years, and they plan to seek regulatory approvals as soon as possible.

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

Covid Delta variant behind bulk of breakthrough infections in India

Covid Delta variant behind bulk of breakthrough infections in India

Rediff.com20 Aug 2021

Breakthrough infections of coronavirus cases comprise a very high proportion of the Delta variant, the INSACOG, a genome sequencing government consortium of laboratories, has said.

Ganguly to be discharged from hospital on Wednesday

Ganguly to be discharged from hospital on Wednesday

Rediff.com5 Jan 2021

Ganguly will be ready for the next course of procedures or medical intervention after about 2-3 weeks

 Covaxin shows robust response

Covaxin shows robust response

Rediff.com17 Dec 2020

Bharat Biotech is in the middle of conducting a phase 3 trial with 22,000 subjects.